Two Aussie biotechs with Capital Raises this week have resulted in their share price to increase, not slump like Kazias after its CR.
I guess, its how the CR is managed, timed and executed that makes the difference
Just my opinion, not advice
- Forums
- ASX - By Stock
- Paxalisib GBM AGILE study
Two Aussie biotechs with Capital Raises this week have resulted...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)